What concentration of lignocaine (local anesthetic) is recommended for a sphenopalatine block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lignocaine for Sphenopalatine Block

Use 4% lignocaine (lidocaine) solution for sphenopalatine ganglion block, delivered intranasally via cotton-tipped applicators or atomization device.

Recommended Concentration and Delivery

  • 4% lignocaine is the standard concentration for sphenopalatine ganglion block, as demonstrated in clinical trials and supported by airway anesthesia guidelines 1, 2
  • The solution can be delivered via direct application under visualization or through noninvasive atomization devices 1, 2
  • For intranasal delivery, approximately 0.3 mL per side (total 0.6 mL) is typically sufficient when using atomization 2

Alternative Concentrations

  • 2% lignocaine gel can be used for nasal anesthesia and may be better tolerated than spray formulations with lower systemic absorption 3
  • Some practitioners use concentrations ranging from 2-4% depending on the delivery method and desired depth of anesthesia 3
  • Higher concentrations (4%) may provide more rapid onset of anesthesia, though lower concentrations can be equally effective 3

Maximum Dosing Considerations

  • The maximum safe dose of topical lignocaine is 9 mg/kg lean body weight for airway procedures 3
  • For a 70 kg patient, this translates to approximately 29 mL of 2% solution or 14.5 mL of 4% solution 3
  • Calculate total dose carefully, especially if combining with other local anesthetic techniques (nerve blocks, infiltration) 3
  • In elderly patients or those with hepatic/cardiac impairment, use extra caution and consider dose reduction 3

Clinical Application Technique

  • Add a vasoconstrictor (phenylephrine 0.5%) to the lignocaine solution to reduce bleeding and systemic absorption 3
  • Cocaine should be avoided due to cardiovascular toxicity risk without superior efficacy 3
  • Test adequacy of block before proceeding with the procedure 3

Important Safety Considerations

  • Have lipid emulsion and resuscitation equipment immediately available for potential local anesthetic systemic toxicity 3
  • Monitor for signs of toxicity including perioral numbness, tinnitus, or altered mental status 3
  • The research evidence for sphenopalatine blocks shows mixed efficacy, with one study showing no difference between 4% lidocaine and placebo for pain conditions 1, while another using bupivacaine showed benefit at 24 hours but not at 15 minutes 2

Related Questions

What precautions should be taken with injectable anesthetics, particularly those containing epinephrine, in an elderly patient with a history of microhemorrhage in the right pons undergoing dentistry work?
What is the recommended dosage and administration of local anesthesia, specifically lidocaine (local anesthetic), for medical procedures?
What are the appropriate doses of local anesthetics, including spinal, regional, and local anesthesia?
What is the recommended dose and frequency of benzocaine (local anesthetic) administration?
What is the dose of 0.25% bupivacaine (Marcaine) with epinephrine?
What are the expected syphilis serology results, specifically Enzyme Immunoassay (EIA) and Rapid Plasma Reagin (RPR) titer, for a patient who has completed successful treatment for early-latent syphilis and has not had any subsequent sexual encounters?
What is the best contraceptive method for a patient after evacuation and curettage (D&C) following a molar pregnancy?
What is the most appropriate screening test for Down syndrome in a 40-year-old woman at 12 weeks of gestation?
What is the best recommendation for repeat HIV testing in a 19-year-old female with a history of gonorrhea and chlamydia, but a currently negative HIV test result?
What medication should be started for an elderly patient with dementia symptoms, including memory loss and social withdrawal?
What is the best next step in managing a patient with HIV and persistent low-level viremia on bictegravir (Biktarvy)/emtricitabine (Emtriva)/tenofovir alafenamide (Vemlidy) with an HIV RNA <200 copies/mL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.